SpA (n=11) | SpA+anti-TNF (n=20*) | |
---|---|---|
Disease duration (years) | 4 (0.7–20)† | 9 (00.8–20)† |
Age (years) | 29.5 (22–38)† | 30 (22–40)† |
BASDAI | 4.38 (2.7–7.1)† | 1.5 (0–3.78)† |
CRP (mg/l) | 7.5 (3–176)† | 5.0 (3–67)† |
Treatment | ||
Infliximab, n | 0 | 16 |
Etanercept, n | 0 | 3 |
Adalimumab, n | 0 | 1 |
Sulfasalazine, n | 2 | 0 |
Methotrexate, n | 1 | 5 |
Azathioprine, n | 0 | 1 |
NSAID, n | 4 | 0 |
Duration of anti-TNF treatment before sperm analysis (months) | – | 27 (4–57)† |